Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 205 results found. Search for [ BioNTech ]

Results 40 to 60 of 205
BusinessToday.In
November 17, 2020
These early efficacy figures don't tell the whole story. The data results are based on a relatively smaller group of participants who received these vaccine shots. The actual efficacy could be known only after the final results are out as Phase 3 clinical trials end


BusinessToday.In
November 17, 2020
Pfizer filed a possible patent infringement petition against both companies in the United States District Court for the District of Delaware and two counts last week


BusinessToday.In
November 17, 2020
Moderna had announced on November 16 that after Phase 3 of trials their COVID-19 vaccine candidate was 94.5% effective in preventing coronavirus infection


Manoj Sharma
November 17, 2020
Dr Ali Nouri, molecular biologist and President, Federation of American Scientists, has explained how these vaccine candidates work in simplest possible way on Twitter


Reuters
November 17, 2020
Interim data from a late-stage trial indicated Moderna's vaccine was 94.5% effective in preventing COVID-19


BusinessToday.In
November 17, 2020
Moderna had announced on November 16 that after Phase 3 of trials their COVID-19 vaccine candidate was 94.5% effective in preventing coronavirus infection


BusinessToday.In
November 17, 2020
Moderna had announced on November 16 that after Phase 3 of trials their COVID-19 vaccine candidate was 94.5% effective in preventing coronavirus infection


Aseem Thapliyal
November 17, 2020
Nifty too hit a record high in early trade with the index risingabove 12,900 for the first time ever


BusinessToday.In
November 17, 2020
The early results provide strong signals that the coronavirus vaccine could prevent a majority of disease when large groups of people are vaccinated. However, the actual efficacy could be known only after the final results are out once the stage 3 trials end


Reuters
November 17, 2020
The Hyderabad-based firm initiated phase I and phase II trials of its vaccine candidate after getting the green signal from the Drugs Controller General of India


BusinessToday.In
November 17, 2020
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


BusinessToday.In
November 16, 2020
Moderna stated that its COVID-19 vaccine candidate remains stable for 30 days at 2-degree Celsius to 8-degree Celsius, the temperature of a standard home or medical refrigerator


BusinessToday.In
November 16, 2020
BioNTech's CEO and Co-founder Ugur Sahin said, if everything continues to go well, the vaccine would begin to be delivered at the \"end of this year, beginning of next year.\"


Reuters
November 16, 2020
The U.S. drugmaker plans to enrol up to 30,000 participants for the study and run it in parallel with a one-dose trial with as many as 60,000 volunteers that began in September


Aseem Thapliyal
November 15, 2020
Over the past week, the 30-share BSE Sensex jumped 1,744.92 points or 4.16 per cent


BusinessToday.In
November 15, 2020
As per Anthony Fauchi, the Pfizer's vaccine distribution process in the US will start in December. This, he said, will also help reduce the daily spike in coronavirus cases, which reached 1.9 lakh this week


BusinessToday.In
November 13, 2020
Pfizer and BioNTech recently announced that their vaccine candidate BNT162b2 has shown over 90 per cent efficacy in preventing coronavirus, as per data from Phase III clinical trials


Reuters
November 13, 2020
The GAVI alliance said on Friday that the funds for an advance market commitment (AMC) will allow the COVAX facility to buy an initial one billion vaccine doses for 92 eligible countries


Reuters
November 13, 2020
Since January, Fauci has served on President Donald Trump's White House Coronavirus Task Force, a position that has frequently put him at odds with the president, who has sought to downplay the pandemic


BusinessToday.In
November 13, 2020
On nations hoarding vaccine stocks to meet their requirements first, Dmitriev said it is not about vaccine nationalism and that India is an important partner


PAGES 3 OF 11  12345